Published in Oncol Lett on February 17, 2017
Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol (2001) 6.73
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene (2006) 6.61
TRAIL and apoptosis induction by TNF-family death receptors. Oncogene (2003) 2.75
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis (2002) 2.70
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ (2004) 2.17
Enhancing TRAIL-induced apoptosis by Bcl-X(L) siRNA. Cancer Biol Ther (2005) 1.61
Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res (2000) 1.61
BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ (2010) 1.34
Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Gynecol Oncol (2001) 1.26
Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysis. Proc Natl Acad Sci U S A (2012) 1.23
Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP. Oncogene (2004) 1.18
Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. J Cell Biol (2001) 1.16
Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci (2005) 1.11
Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis. Blood (2006) 1.09
Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling. Cell Death Differ (2001) 1.07
The role of TRADD in death receptor signaling. Cell Cycle (2012) 1.00
Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways. Int J Oncol (2011) 0.97
TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid. J Biol Chem (2002) 0.97
A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning. Toxicon (2010) 0.96
Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9. Cell Cycle (2012) 0.96
Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Exp Cell Res (2004) 0.96
Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition. Exp Toxicol Pathol (2013) 0.95
Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells. Oncogene (2007) 0.95
p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax. Int J Oncol (2013) 0.94
Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines. Cancer Res (2003) 0.93
Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. J Interferon Cytokine Res (2002) 0.90
Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling. Pharmacol Ther (2013) 0.90
Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway. Apoptosis (2011) 0.90
Photoactive extracts from Thevetia peruviana with antifungal properties against Cladosporium cucumerinum. J Photochem Photobiol B (2003) 0.89
Gomisin N enhances TNF-α-induced apoptosis via inhibition of the NF-κB and EGFR survival pathways. Mol Cell Biochem (2010) 0.88
Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation. Int J Oncol (2013) 0.86
Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation. Carcinogenesis (2009) 0.86
STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs. Biochem Biophys Res Commun (1999) 0.86
Bufotalin sensitizes death receptor-induced apoptosis via Bid- and STAT1-dependent pathways. Int J Oncol (2011) 0.85
Vanillin enhances TRAIL-induced apoptosis in cancer cells through inhibition of NF-kappaB activation. In Vivo (2010) 0.83
Isolation and characterization of some phytochemicals from Indian traditional plants. Biotechnol Res Int (2012) 0.82
Cardiac glycosides from Yellow Oleander (Thevetia peruviana) seeds. Phytochemistry (2011) 0.80
Identification of plant extracts sensitizing breast cancer cells to TRAIL. Oncol Rep (2013) 0.80
ATM kinase promotes both caspase-8 and caspase-9 activation during TNF-α-induced apoptosis of HeLa cells. FEBS Lett (2014) 0.80
Cisplatin augments FAS-mediated apoptosis through lipid rafts. Anticancer Res (2010) 0.79
Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt. Oncol Rep (2013) 0.78
Flavanone and flavonol glycosides from the leaves of Thevetia peruviana and their HIV-1 reverse transcriptase and HIV-1 integrase inhibitory activities. Chem Pharm Bull (Tokyo) (2002) 0.78
Cardenolide glycosides of Thevetia peruviana and triterpenoid saponins of Sapindus emarginatus as TRAIL resistance-overcoming compounds. J Nat Prod (2009) 0.76
p38-Mediated phosphorylation of Eps15 endocytic adaptor protein. FEBS Lett (2013) 0.83
Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer. Int J Oncol (2015) 0.81
Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2. Nat Commun (2015) 0.81
Immune adjuvant effect of Juzentaihoto, a Japanese traditional herbal medicine, on tumor vaccine therapy in a mouse model. Int J Oncol (2015) 0.77
The long-term effects of a kampo medicine, juzentaihoto, on maintenance of antibody titer in elderly people after influenza vaccination. Evid Based Complement Alternat Med (2013) 0.76
Effect of keishibukuryogan on genetic and dietary obesity models. Evid Based Complement Alternat Med (2015) 0.75
Analysis of Chemical Properties of Edible and Medicinal Ginger by Metabolomics Approach. Biomed Res Int (2015) 0.75
Coptidis Rhizoma induces intrinsic apoptosis through BAX and BAK activation in human melanoma. Oncol Rep (2017) 0.75